The daily business briefing: June 18, 2021
The U.S. lifts tariff on Scotch, jobless claims rise after falling six straight weeks, and more
1. U.S. lifts Trump tariff on Scotch
The U.S. and Britain agreed Thursday to a five-year suspension of 25 percent tariffs on certain goods imposed under former President Donald Trump as part of a long trade dispute over subsidies to Boeing and its European rival, Airbus. The Biden administration and the European Union resolved the aerospace dispute earlier this week, paving the way for the suspension of the 2019 retaliatory tariffs. For Britain, which was part of the EU in 2019 but isn't anymore, the highest-profile export hit in the trade war was single malt Scotch. The 25 percent tariffs on Scotch led to a 30 percent drop in exports to the U.S. in the 18 months through March 2021, the Scotch Whisky Association says. British tariffs on American whiskeys remain in place as part of a different EU-U.S. dispute.
2. Jobless claims unexpectedly rise
The number of Americans filing new applications for unemployment benefits rose by 37,000 last week to 412,000, the first weekly increase since April. The number has dropped most weeks this year as coronavirus infections and deaths have fallen, bolstering the economic recovery from the coronavirus crisis. Economists had expected weekly applications for benefits to fall again this week after six straight weeks of pandemic-era lows. The four-week average of claims dropped by 8,000 last week to 395,000, the lowest four-week average since the pandemic hit the United States in March 2020. AnnElizabeth Konkel, economist at the Indeed Hiring Lab, said the uptick showed that "we are not back to a 'normal' level yet," but the good news is that initial claims "are no longer astronomically high."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Wall Street Journal The Associated Press
3. Supreme Court rules former West Africa child slaves can't sue U.S. companies
The Supreme Court ruled against six former child slaves from Mali in West Africa who sued food companies Nestle and Cargill accusing them of perpetuating illegal working conditions in the global chocolate industry. The plaintiffs said in the 15-year-old suit that they were trafficked to cocoa plantations in Ivory Coast, and forced to work. They said the companies' pressure to keep down cocoa prices fueled a system that relied on enslaved children on cocoa farms in Ivory Coast and Ghana. Associate Justice Clarence Thomas, writing for the court, said that the plaintiffs couldn't sue because the actions took place in Ivory Coast, not the United States. Associate Justice Samuel Alito noted that the suit "didn't even allege that [Nestle and Cargill] knew about forced child labor."
4. Stock futures flat as Dow faces losing week
U.S. stock futures were mixed early Friday as the market struggled for footing after the Federal Reserve accelerated its timetable for raising interest rates. Futures for the Dow Jones Industrial Average and the S&P 500 were down by less than 0.1 percent several hours before the opening bell, while those of the tech-heavy Nasdaq were up by 0.1 percent. The Dow dropped by 0.6 percent on Thursday, putting it down by 1.9 percent this week. The S&P 500 fell by less than 0.1 percent. The Nasdaq rose by 0.9 percent on Thursday. The Fed this week kept interest rates unchanged near zero, but moved up its planned interest rate hikes as it raised its 2021 inflation expectation to 3.4 percent.
5. U.S. to invest $3.2 billion in antiviral pills for COVID-19
The Biden administration will invest $3.2 billion to speed up development of antiviral pills to treat COVID-19, the Department of Health and Human Services said Thursday. Dr. Anthony Fauci, chief medical adviser to President Biden, said the money, which will come from the $1.9 trillion March coronavirus relief package, could accelerate clinical trials already underway for some antiviral pills, possibly making some available by the end of 2021. Patients could take them at home early in an infection. "New antivirals that prevent serious COVID-19 illness and death, especially oral drugs that could be taken at home early in the course of disease, would be powerful tools for battling the pandemic and saving lives," Fauci said in a Thursday briefing.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.
-
Magazine solutions - December 27, 2024 / January 3, 2025
Puzzles and Quizzes Issue - December 27, 2024 / January 3, 2025
By The Week US Published
-
Magazine printables - December 27, 2024 / January 3, 2025
Puzzles and Quizzes Issue - December 27, 2024 / January 3, 2025
By The Week US Published
-
Why ghost guns are so easy to make — and so dangerous
The Explainer Untraceable, DIY firearms are a growing public health and safety hazard
By David Faris Published
-
The daily business briefing: January 24, 2024
Business Briefing The S&P 500 sets a third straight record, Netflix adds more subscribers than expected, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 23, 2024
Business Briefing The Dow and S&P 500 set fresh records, Bitcoin falls as ETF enthusiasm fades, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 22, 2024
Business Briefing FAA recommends inspections of a second Boeing 737 model, Macy's rejects Arkhouse bid, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 19, 2024
Business Briefing Macy's to cut 2,350 jobs, Congress averts a government shutdown, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 18, 2024
Business Briefing Shell suspends shipments in the Red Sea, December retail sales beat expectations, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 17, 2024
Business Briefing Judge blocks JetBlue-Spirit merger plan, Goldman Sachs beats expectations with wealth-management boost, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 16, 2024
Business Briefing Boeing steps up inspections on 737 Max 9 jets, Zelenskyy fights for world leaders' attention at Davos, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 12, 2024
Business Briefing Inflation was slightly hotter than expected in December, Hertz is selling a third of its EVs to buy more gas cars, and more
By Harold Maass, The Week US Published